FIELD: medicine, pharmacy. SUBSTANCE: invention proposes a pharmaceutical composition containing lyophilized water- -insoluble complex of camptothecin and phospholipid and pharmaceutically acceptable vehicle. EFFECT: improved stability of composition. 15 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PROLIPOSOMAL POWDER FOR INHALATION | 1995 |
|
RU2162689C2 |
| NEW THERMALLY-SENSITIVE LIPOSOMES CONTAINING THERAPEUTIC AGENTS | 2008 |
|
RU2497499C2 |
| DEPOT FORMULATIONS OF HYDROPHOBIC ACTIVE INGREDIENT AND METHODS FOR PREPARATION THEREOF | 2013 |
|
RU2678433C2 |
| DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
| METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
| BIS(THIO-HYDRAZIDE AMIDE) COMPOSITION | 2006 |
|
RU2433822C2 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL DELIVERY IN FORM OF LYOPHILIZATE AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370258C2 |
| DISPERSABLE MICROPARTICLES STABILIZED WITH PHOSPHOLIPID | 1999 |
|
RU2233654C2 |
| METHOD FOR PRODUCING LIPID MIXTURE AND LIPOSOMAL ORAL ANTIVIRAL THERAPEUTIC AND PROPHYLACTIC AGENT USING SAID LIPID MIXTURE | 2020 |
|
RU2746320C1 |
| ULTRASONIC CONTRAST MEDIUMS AND METHOD OF PRODUCTION THEREOF | 2004 |
|
RU2345793C2 |
